NUZYRA
Live / Registered — Registered (as of 07 Feb 2023)
What this means for you
Registered since 07 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88438211
- Registration number
- 6974799
- Mark type
- Stylized text
- Filed
- 20 May 2019
- Published for opposition
- 29 Sept 2020
- Registered
- 07 Feb 2023
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; medical information services, namely, providing information to physicians, healthcare professionals, and patients on the topics of health issues, pharmaceutical products, and health awareness in the field of infectious diseases; health care services, namely, providing patient access programs to provide eligible patients with streamlined access to drugs; dispensing of pharmaceuticals; providing an internet website for medical professionals and medical patients that provides cumulative medical information for use by medical professionals and medical patients
Owner
- Paratek Pharmaceuticals, Inc., Boston, MA, US
- Paratek Pharmaceuticals, Inc., Boston, MA, US
- Paratek Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 28 May 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Nov 2022 — USE AMENDMENT FILED
- 10 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Nov 2022 — TEAS STATEMENT OF USE RECEIVED
- 18 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2022 — SOU EXTENSION 3 GRANTED
- 16 May 2022 — SOU EXTENSION 3 FILED
- 16 May 2022 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2021 — SOU EXTENSION 2 GRANTED